These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38596427)

  • 1. Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy.
    Hambrick HR; Cervantes F; Dong M; Tang P; Arbough T; Vinks AA; Mizuno T; Goldstein SL; Kaplan J; Girdwood ST
    J Pediatr Pharmacol Ther; 2024 Apr; 29(2):180-187. PubMed ID: 38596427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
    Selig DJ; DeLuca JP; Chung KK; Pruskowski KA; Livezey JR; Nadeau RJ; Por ED; Akers KS
    J Clin Pharm Ther; 2022 Aug; 47(8):1091-1102. PubMed ID: 35352374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
    Pavia K; Hambrick HR; Paice K; Tang P; Punt N; Kaplan J; Goldstein SL; Vinks AA; Mizuno T; Tang Girdwood S
    J Antimicrob Chemother; 2023 Sep; 78(9):2140-2147. PubMed ID: 37466170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy.
    Butragueño-Laiseca L; Marco-Ariño N; Troconiz IF; Grau S; Campillo N; García X; Padilla B; Fernández SN; Slöcker M; Santiago MJ
    Clin Microbiol Infect; 2022 Sep; 28(9):1287.e9-1287.e15. PubMed ID: 35390523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.
    Tang Girdwood S; Tang P; Fenchel M; Dong M; Stoneman E; Jones R; Ostermeier A; Curry C; Forton M; Hail T; Mullaney R; Diseroad E; Punt N; Kaplan J; Vinks AA
    Pharmacotherapy; 2023 Jul; 43(7):609-621. PubMed ID: 36727212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients.
    Hambrick HR; Fei L; Pavia K; Kaplan J; Mizuno T; Tang P; Schuler E; Benoit S; Girdwood ST
    Transplant Cell Ther; 2024 Jun; 30(6):614.e1-614.e11. PubMed ID: 38522579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children.
    Butragueño-Laiseca L; Troconiz IF; Grau S; Campillo N; Padilla B; Fernández SN; Slöcker M; Herrera L; Santiago MJ
    Antimicrob Agents Chemother; 2024 Apr; ():e0172923. PubMed ID: 38656186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
    Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
    Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Gilder E; Kim HS; Lim SY; McGuinness S; Parke R; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA;
    Clin Pharmacokinet; 2022 Jun; 61(6):847-856. PubMed ID: 35253107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic disturbances and oliguria during continuous kidney replacement therapy in critically ill children.
    Fernández Lafever SN; López J; González R; Solana MJ; Urbano J; López-Herce J; Butragueño L; Santiago MJ
    Pediatr Nephrol; 2021 Jul; 36(7):1889-1899. PubMed ID: 33433709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
    Simon N; Dussol B; Sampol E; Purgus R; Brunet P; Lacarelle B; Berland Y; Bruguerolle B; Urien S
    Clin Pharmacokinet; 2006; 45(5):493-501. PubMed ID: 16640454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
    Ollivier J; Carrié C; d'Houdain N; Djabarouti S; Petit L; Xuereb F; Legeron R; Biais M; Breilh D
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Modeling of Total and Free Ceftriaxone in Critically Ill Children and Young Adults and Monte Carlo Simulations Support Twice Daily Dosing for Target Attainment.
    Tang Girdwood S; Dong M; Tang P; Stoneman E; Jones R; Yunger T; Ostermeier A; Curry C; Forton M; Hail T; Mullaney R; Lahni P; Punt N; Kaplan J; Vinks AA
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0142721. PubMed ID: 34633847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe.
    Daverio M; Cortina G; Jones A; Ricci Z; Demirkol D; Raymakers-Janssen P; Lion F; Camilo C; Stojanovic V; Grazioli S; Zaoral T; Masjosthusmann K; Vankessel I; Deep A;
    JAMA Netw Open; 2022 Dec; 5(12):e2246901. PubMed ID: 36520438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Thy M; Urien S; Foissac F; Bouazza N; Gana I; Bille E; Béranger A; Toubiana J; Berthaud R; Lesage F; Renolleau S; Tréluyer JM; Benaboud S; Oualha M
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0113522. PubMed ID: 36342152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study.
    Gijsen M; Dreesen E; Van Daele R; Annaert P; Debaveye Y; Wauters J; Spriet I
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34064676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study.
    Hartman SJF; Upadhyay PJ; Hagedoorn NN; Mathôt RAA; Moll HA; van der Flier M; Schreuder MF; Brüggemann RJ; Knibbe CA; de Wildt SN
    Clin Pharmacokinet; 2021 Oct; 60(10):1361-1372. PubMed ID: 34036552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.
    Starr MC; Gist KM; Zang H; Ollberding NJ; Balani S; Cappoli A; Ciccia E; Joseph C; Kakajiwala A; Kessel A; Muff-Luett M; Santiago Lozano MJ; Pinto M; Reynaud S; Solomon S; Slagle C; Srivastava R; Shih WV; Webb T; Menon S;
    Am J Kidney Dis; 2024 Feb; ():. PubMed ID: 38364956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.